These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1278664)

  • 1. [The frequency and clinical significance of incomplete removal of epithelial lesions on the cervix uteri by conisation (author's transl)].
    Kraus H; Schuhmann R; Breinl H; Piroth H
    Geburtshilfe Frauenheilkd; 1976 May; 36(5):439-44. PubMed ID: 1278664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complete and incomplete removal of precancerous conditions by conization].
    Kraus H; Schuhmann RA; Breinl H
    Fortschr Med; 1983 Oct; 101(39):1762-5. PubMed ID: 6642381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Follow-up and management of patients with incomplete cone biopsies for dysplasias (author's transl)].
    Kraus H; Prinz W
    Geburtshilfe Frauenheilkd; 1979 Jan; 39(1):58-60. PubMed ID: 217797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual disease after cone biopsy: completeness of excision and follow-up cytology as predictive factors.
    Buxton EJ; Luesley DM; Wade-Evans T; Jordan JA
    Obstet Gynecol; 1987 Oct; 70(4):529-32. PubMed ID: 3627622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conisation in stage Ia cervix cancer].
    Vavra N; Nagele F; Rosen A; Klein M; Barrada M; Buxbaum P; Sevelda P
    Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):397-400. PubMed ID: 7926571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The extent of the atypical squamous epithelium of the cervix uteri (author's transl)].
    Holzer E; Picked H
    Arch Geschwulstforsch; 1975; 45(1):79-91. PubMed ID: 1156120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of the conservative management of carcinoma in situ of the uterine cervix by conization (author's transl)].
    Holzer E
    Geburtshilfe Frauenheilkd; 1976 Aug; 36(8):630-9. PubMed ID: 976703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study with serial sectioning of 312 preclinical cancers of the uterine cervix. Indications for selective treatment (author's transl)].
    Bremond A; Dargent D; Frappart L; Beau G
    Bull Cancer; 1979; 66(4):455-9. PubMed ID: 526633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smear biopsies: a cause of negative follow-up biopsies in patients with premalignant conditions of the uterine cervix.
    Berner A; Høeg K; Oppedal BR
    Diagn Gynecol Obstet; 1980; 2(2):99-101. PubMed ID: 7439010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological and diagnostic analyses of 1194 cone biopsies (author's transl)].
    Dietl J; Buchholz F; Semm K
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):173-8. PubMed ID: 7215755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoma in situ of the uterine cervix: treatment (author's transl)].
    Burghardt E
    Bull Cancer; 1979; 66(4):425-34. PubMed ID: 575059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent carcinoma in situ of the uterine cervix (author's transl)].
    Anastasiadis P; von Lüdinghausen M
    Geburtshilfe Frauenheilkd; 1979 Jun; 39(6):479-83. PubMed ID: 478259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of residual neoplasia based on histopathology and margin status of conization specimens.
    Chang DY; Cheng WF; Torng PL; Chen RJ; Huang SC
    Gynecol Oncol; 1996 Oct; 63(1):53-6. PubMed ID: 8898168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of cone biopsy margins in the management of patients with cervical neoplasia.
    Lubicz S; Ezekweche C; Allen A; Schiffer M
    J Reprod Med; 1984 Mar; 29(3):179-84. PubMed ID: 6726696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of premalignant lesions of the uterine cervix by means of moderate heat thermosurgery using the SEMM coagulator.
    Staland B
    Ann Chir Gynaecol; 1978; 67(3):112-6. PubMed ID: 686641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary invasive and preinvasive carcinomas of the vagina following hysterectomy for treatment of analogous lesions of the cervix (author's transl)].
    Schneider ML
    Geburtshilfe Frauenheilkd; 1978 Jun; 38(6):452-6. PubMed ID: 669232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.